Espinosa Lluís, Marruecos Laura
Cancer Research Program, Institut Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
Biomedicines. 2021 Sep 21;9(9):1278. doi: 10.3390/biomedicines9091278.
IκBα is considered to play an almost exclusive role as inhibitor of the NF-κB signaling pathway. However, previous results have demonstrated that SUMOylation imposes a distinct subcellular distribution, regulation, NF-κB-binding affinity and function to the IκBα protein. In this review we discuss the main alterations of IκBα found in cancer and whether they are (most likely) associated with NF-κB-dependent or NF-κB-independent (moonlighting) activities of the protein.
IκBα被认为几乎是NF-κB信号通路的唯一抑制剂。然而,先前的研究结果表明,SUMO化作用赋予IκBα蛋白独特的亚细胞分布、调节、NF-κB结合亲和力和功能。在这篇综述中,我们讨论了在癌症中发现的IκBα的主要变化,以及它们是否(很可能)与该蛋白的NF-κB依赖性或NF-κB非依赖性(兼职)活性相关。